Recent advances in vaccine and immunotherapy for COVID-19

Abstract

The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Rabaan, A. A., Al-Ahmed, S. H., Sah, R., Al-Tawfiq, J. A., Al-Qaaneh, A. M., Al-Jamea, L. H., ... & Rodriguez-Morales, A. J. (2020). Recent advances in vaccine and immunotherapy for COVID-19. Human Vaccines & Immunotherapeutics, 16(12), 3011-3022. https://doi.org/10.1080/21645515.2020.1825896
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Human Vaccines & Immunotherapeutics
Source
Publisher
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}